akash.verma@cenmed.com
(732) 447-1115-
68-1001-11Azenta Life Sciences dual-coded tubes feature a 2D code and human readable number on tube base, allowing compatibility with low throughput manual, semi-automated or fully automated workflows on integrated platforms Next Generation manufacturing -
68-1001-01Azenta Life Sciences dual-coded tubes feature a 2D code and human readable number on tube base, allowing compatibility with low throughput manual, semi-automated or fully automated workflows on integrated platforms Next Generation manufacturing -
68-0701-12Azenta Life Sciences tri-coded tubes offer unequaled sample audit traceability, enabling sample tracking and data sharing between multiple users, labs, locations and automation capabilities Next Generation manufacturing techniques Code readable -
66-62319-LIntroFluidX Next-Gen dual-coded tubes feature a 2D code and human readable number on tube base, allowing compatibility with low throughput manual, semi-automated or fully automated workflows on integrated platforms Next Generation manufacturing -
66-62317-LIntroFluidX Next-Gen dual-coded tubes feature a 2D code and human readable number on tube base, allowing compatibility with low throughput manual, semi-automated or fully automated workflows on integrated platforms Next Generation manufacturing -
7009002TAS-System is a powerful thermal cycler temperature validation system that includes a control module with integrated real-time display, probe plates accommodating fixed or variable probes, and powerful PC software. It reliably analyzes data and -
30529066Designed for Routine Weighing Applications in Your Workplace -
-
-
E654834-1mlEP1013 (F1013) is a broad-spectrum caspase selective inhibitor, used in the research of type 1 diabetesIn VivoEP1013 (1, 3, 10 mg/kg) significantly improves marginal islet mass function. Two animals in the 10 mg/kg EP1013 treatment group exhibit -
E647027-5mgEP1013 (F1013) is a broad-spectrum caspase selective inhibitor, used in the research of type 1 diabetesIn VivoEP1013 (1, 3, 10 mg/kg) significantly improves marginal islet mass function. Two animals in the 10 mg/kg EP1013 treatment group exhibit -
E647027-50mgEP1013 (F1013) is a broad-spectrum caspase selective inhibitor, used in the research of type 1 diabetesIn VivoEP1013 (1, 3, 10 mg/kg) significantly improves marginal islet mass function. Two animals in the 10 mg/kg EP1013 treatment group exhibit
